# Lisata Therapeutics, Inc.: Form 8-K, filed Jun 1, 2026

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2026-06-01
- Accepted by EDGAR: Jun 1, 2026, 06:03 ET
- Period: 2026-06-01
- Accession: 0001140361-26-023397
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000114036126023397/ef20075280_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000114036126023397/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000114036126023397/ef20075280_8k.htm

Filed Jun 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-023397. Last ingested by Listed: Nov 10, 2026, 04:21 ET. No prices; not investment advice.